None listed
Conditions
Interventions
Intervention1: Curcumin Gummies
: Route of Administration: Oral
Mode of Usage: Chew Gummies thoroughly and completely before swallowing.
Frequency: 2 gummies daily
Duration: 30 Day
Intervention2: Vi
Sponsors
Not applicable, Investigator Initiated Trial
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 02 to 12 years old (both inclusive) at the time of parental consent. 2) Overall good health of the child subject is determined by medical examination and history evaluated by the Investigator. 3) Subjectâ??s mother/legal guardian, preferably willing to give a voluntary written informed consent i.e. parental informed consent form and agree to complete study activities and come for regular follow-up with a subject. 4) The subjectâ??s mother/legal guardian for their child is preferably willing to abide by and comply with the study protocol. 5) The subject should not participate in any other clinical study during participation in the current study 6) Subject are agreed to maintain current level of activity through the study.
Exclusion criteria
Exclusion criteria: 1) Subjects with known history of allergies or specific allergic reactions upon using curcumin, vitamins, zinc, pantothenic acid. 2) Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment. 3) Subjects, who in the opinion of the Investigator or the Expert physician are not eligible for enrolment in the study. 4) Subject who are unwilling to provide consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the safety, efficacy and organoleptic properties of test product in healthy children.Timepoint: From baseline Day 01 before taken test product to Day 30 after taken test product | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactMs Megha Yadav
NovoBliss Research Private Limited
Outcome results
None listed